We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cabazitaxel in Platinum Refractory Ovarian Cancer

This study has been terminated.
(Too low inclusion rate. Only 4 patients included over 16 months)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01747239
First Posted: December 11, 2012
Last Update Posted: December 4, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Sanofi
Information provided by (Responsible Party):
Vejle Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)